Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sam Pallerla
Observed name:
Sammaiah Pallerla
Institution:
International AIDS Vaccine Initiative
Observed institution:
International AIDS Vaccine Initiative
ORCID:
0009-0009-7973-0332
Observed ORCID:
0009-0009-7973-0332
OpenAlex ID:
A5106280658
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates
2025
·
Parham Ramezani-Rad
, Ester Marina-Zárate
, et al.
·
Journal of Clinical Investigation
·
23
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP)
2025
·
Sammaiah Pallerla
, Ivan S. Pires
, et al.
·
Journal of Pharmaceutical Sciences
·
16
PDF
Translating Innovation to Clinic: End‐to‐End Bioprocess Development and cGMP Manufacturing of N332‐GT5 HIV Vaccine Candidate for First‐In‐Human Trials (HVTN144)
2026
·
Sammaiah Pallerla
, Shaunak D. Uplekar
, et al.
·
Biotechnology and Bioengineering
·
1
PDF
Scalable Production of a De Novo SARS-CoV-2 Antiviral Miniprotein in Escherichia coli
2026
·
Jinhwan Shin
, Eu-min Kim
, et al.
·
Pharmaceutics
Show more works
View as search
Works count:
4
Citation count:
40
H-index:
2
I10-index:
2
Year
Topic
Type
